Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/29/17
End: 04/29/21
Due: 04/29/22
Phase: N/A
Priority: Normal
Start: 07/15/21
End: 07/15/24
Due: 07/15/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Chemotherapy for Potentially Resectable Locally Advanced Esophagogastric Junction Carcinoma | NCT03211377 | Anyang Tumor Hospital | user2@example.com | None | 2017-03-29 | 2021-04-29 | 2022-04-29 | - | - | 2025-07-14 |
| Anlotinib for Esophageal Cancer (AFEC) | NCT04966611 | Anyang Tumor Hospital | user2@example.com | None | 2021-07-15 | 2024-07-15 | 2025-07-15 | - | - | 2025-07-14 |